Regular aspirin use and gene expression profiles in prostate cancer patients
暂无分享,去创建一个
Jennifer R. Rider | P. Kantoff | T. Gerke | L. Mucci | K. Stopsack | E. Ebot | M. K. Downer | Konrad H. Stopsack
[1] Jennifer R. Rider,et al. Gene expression profiling of prostate tissue identifies chromatin regulation as a potential link between obesity and lethal prostate cancer , 2017, Cancer.
[2] Jacob K. Asiedu,et al. The Drug Repurposing Hub: a next-generation drug library and information resource , 2017, Nature Medicine.
[3] Bin Liu,et al. Aspirin Inhibits IKK-β-mediated Prostate Cancer Cell Invasion by Targeting Matrix Metalloproteinase-9 and Urokinase-Type Plasminogen Activator , 2017, Cellular Physiology and Biochemistry.
[4] Jennifer R. Rider,et al. Perineural Invasion and Risk of Lethal Prostate Cancer , 2017, Cancer Epidemiology, Biomarkers & Prevention.
[5] M. Stampfer,et al. Regular Aspirin Use and the Risk of Lethal Prostate Cancer in the Physicians' Health Study. , 2016, European urology.
[6] L. Mucci,et al. Common medications and prostate cancer mortality: a review , 2017, World Journal of Urology.
[7] Jennifer R. Rider,et al. Prognostic Utility of a New mRNA Expression Signature of Gleason Score , 2016, Clinical Cancer Research.
[8] E. Whitlock,et al. Bleeding Risks With Aspirin Use for Primary Prevention in Adults: A Systematic Review for the U.S. Preventive Services Task Force , 2016, Annals of Internal Medicine.
[9] Yin Cao,et al. Aspirin and colorectal cancer: the promise of precision chemoprevention , 2016, Nature Reviews Cancer.
[10] Jihye Kim,et al. DSigDB: drug signatures database for gene set analysis , 2015, Bioinform..
[11] M. Pollak,et al. The use of aspirin and the risk of mortality in patients with prostate cancer. , 2015, The Journal of urology.
[12] Juancarlos Chan,et al. Gene Ontology Consortium: going forward , 2014, Nucleic Acids Res..
[13] S. Freedland,et al. Daily aspirin use and prostate cancer-specific mortality in a large cohort of men with nonmetastatic prostate cancer. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[14] Peter Kraft,et al. Association of Prostate Cancer Risk Variants with Gene Expression in Normal and Tumor Tissue , 2014, Cancer Epidemiology, Biomarkers & Prevention.
[15] R. Spitale,et al. Molecular targets of aspirin and cancer prevention , 2014, British Journal of Cancer.
[16] Morten Wang Fagerland,et al. Association between use of β-blockers and prostate cancer-specific survival: a cohort study of 3561 prostate cancer patients with high-risk or metastatic disease. , 2014, European urology.
[17] L. Sharp,et al. A cohort study investigating aspirin use and survival in men with prostate cancer. , 2014, Annals of oncology : official journal of the European Society for Medical Oncology.
[18] Peter Kraft,et al. Aspirin use, 8q24 single nucleotide polymorphism rs6983267, and colorectal cancer according to CTNNB1 alterations. , 2013, Journal of the National Cancer Institute.
[19] L. Bateman,et al. An alkyne-aspirin chemical reporter for the detection of aspirin-dependent protein modification in living cells. , 2013, Journal of the American Chemical Society.
[20] T. Uchiumi,et al. Prostaglandin receptor EP3 mediates growth inhibitory effect of aspirin through androgen receptor and contributes to castration resistance in prostate cancer cells. , 2013, Endocrine-related cancer.
[21] D. Powe,et al. Low-dose aspirin and survival in men with prostate cancer: a study using the UK Clinical Practice Research Datalink , 2013, Cancer Causes & Control.
[22] Stacey A. Kenfield,et al. Aspirin Use after a Prostate Cancer Diagnosis and Cancer Survival in a Prospective Cohort , 2012, Cancer Prevention Research.
[23] Anthony V D'Amico,et al. Aspirin use and the risk of prostate cancer mortality in men treated with prostatectomy or radiotherapy. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[24] M. Parmar,et al. Celecoxib plus hormone therapy versus hormone therapy alone for hormone-sensitive prostate cancer: first results from the STAMPEDE multiarm, multistage, randomised controlled trial , 2012, The Lancet. Oncology.
[25] P. Rothwell,et al. Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials , 2011, The Lancet.
[26] Gary D Bader,et al. Enrichment Map: A Network-Based Method for Gene-Set Enrichment Visualization and Interpretation , 2010, PloS one.
[27] Wenyan Lu,et al. Suppression of Wnt/beta-catenin signaling inhibits prostate cancer cell proliferation. , 2009, European journal of pharmacology.
[28] Yong J. Lee,et al. Aspirin Enhances Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand-Mediated Apoptosis in Hormone-Refractory Prostate Cancer Cells through Survivin Down-Regulation , 2007, Molecular Pharmacology.
[29] Yan Liu,et al. Risk factors for prostate cancer incidence and progression in the health professionals follow‐up study , 2007, International journal of cancer.
[30] Paul A Clemons,et al. The Connectivity Map: Using Gene-Expression Signatures to Connect Small Molecules, Genes, and Disease , 2006, Science.
[31] Y. Kwon,et al. Pretreatment of Acetylsalicylic Acid Promotes Tumor Necrosis Factor-related Apoptosis-inducing Ligand-induced Apoptosis by Down-regulating BCL-2 Gene Expression* , 2005, Journal of Biological Chemistry.
[32] Pablo Tamayo,et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[33] K. Hess,et al. Nuclear factor kappa B activation is a potential target for preventing pancreatic carcinoma by aspirin , 2005, Cancer.
[34] B. Pittman,et al. Regression of Mouse Prostatic Intraepithelial Neoplasia by Nonsteroidal Anti-inflammatory Drugs in the Transgenic Adenocarcinoma Mouse Prostate Model , 2004, Clinical Cancer Research.
[35] D. Sliva,et al. Aspirin inhibits highly invasive prostate cancer cells. , 2003, International journal of oncology.
[36] R. Rotem,et al. Contrasting effects of aspirin on prostate cancer cells: Suppression of proliferation and induction of drug resistance , 2000, The Prostate.
[37] X. Chen,et al. Suppression of inducible cyclooxygenase 2 gene transcription by aspirin and sodium salicylate. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[38] A. Deane,et al. Identifiable factors in post-prostatectomy haemorrhage: the role of aspirin. , 1990, British journal of urology.
[39] Final report on the aspirin component of the ongoing Physicians' Health Study. , 1989, The New England journal of medicine.
[40] P. Amrein,et al. Aspirin-induced prolongation of bleeding time and perioperative blood loss. , 1981, JAMA.